|
Autoantibody Profiling for Serological Detection of Head and Neck Cancer
|
1R43CA139806-01
|
$217,801
|
|
Khattar, Nada
|
20/20 GENESYSTEMS, INC.
|
|
Profiling Autoantibodies in Non-small Cell Lung Cancer with Fusion Protein-Peptid
|
1R43CA141963-01
|
$183,927
|
|
Khattar, Nada
|
20/20 GENESYSTEMS, INC.
|
|
Novel Small-molecule TNF-a Modulators as Chemoprotective Agents
|
1R43CA141749-01
|
$154,852
|
|
SHAW, JIAJIU
|
21ST CENTURY THERAPEUTICS, INC.
|
|
Early Warning Method and Technologies for Improving Cancer Care and Targeted Inte
|
1R43CA141899-01
|
$100,000
|
|
Sairamesh, Jakka
|
360FRESH, INC.
|
|
A novel magnetic resonance detector for early diagnosis of bladder cancer recurre
|
1R43CA139799-01
|
$189,480
|
|
Fukushima, Eiichi
|
ABQMR, INC.
|
|
Targeted Prodrug Chemotherapy for Prostate Cancer
|
1R43CA139677-01A1
|
$159,988
|
|
Wu, Jenny
|
ACADUCEUS PHARMACEUTICS, INC.
|
|
Dual Integrin and GRPR Targeted Radiotherapy of Prostate Cancer
|
1R43CA139678-01
|
$100,000
|
|
WU, Jenny
|
ACADUCEUS PHARMACEUTICS, INC.
|
|
Health Fotonovela Strips for Spanish Language Newspapers
|
1R43CA135999-01A1
|
$100,001
|
|
Matiella, Ana
|
ACMA SOCIAL MARKETING
|
|
Low-Intensity Ultrasound for Treating Tumor Vasculature
|
1R43CA139657-01
|
$145,340
|
|
Wood, Andrew
|
ACOUSTIC THERAPEUTICS
|
|
Data acquisition system for multiplex analysis of color encoded particles
|
1R42CA140109-01
|
$100,231
|
|
Gorbovitski, Boris
|
ADVANCED BIOMEDICAL MACHINES, INC.
|
|
Antiangiogenic and antitumoral therapy delivered by a dual-expression L. monocyto
|
1R43CA137915-01A1
|
$210,739
|
|
Wallecha, Anu
|
ADVAXIS, INC.
|
|
Regulation of MMP-9 mRNA stability and tumor growth by alpha3 beta1 integrin
|
5R01CA129637-02
|
$325,775
|
|
DIPERSIO, C
|
ALBANY MEDICAL COLLEGE
|
|
Regulation of Tumor Cell Migration by Mitochondrial Superoxide Dismutase
|
5F32CA134165-02
|
$55,310
|
|
Hempel, Nadine
|
ALBANY MEDICAL COLLEGE
|
|
KLF8 Regulation of EMT Tumor Metastasis
|
1R01CA132977-01A2
|
$290,359
|
|
ZHAO, JIHE
|
ALBANY MEDICAL COLLEGE
|
|
Identification and Classification of Epigenetic Changes in Head and Neck Cancer
|
1R21CA131648-01A2
|
$219,120
|
|
BELBIN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Old Drugs and New Strategies for Tumor Metastasis
|
5R01CA129598-02
|
$249,000
|
|
BRESNICK, ANNE
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
MOTILITY AND INVASION
|
5P01CA100324-07
|
$2,056,747
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Novel Methods for Detecting Cell Interactions in the Tumor Microenvironment
|
5U54CA126511-04
|
$548,821
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Proton-coupled folate/antifolate transport
|
2R01CA082621-11
|
$526,718
|
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
$196,362
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence
|
1R01CA133010-01A2
|
$599,204
|
$299,602
|
Gunter, Marc
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
R-Cadherin in Breast Cancer Suppression
|
1R01CA136854-01A1
|
$344,450
|
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
The transcriptional basis of tumor promotion
|
2R01CA104292-06A2
|
$374,795
|
|
LOCKER, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Chemical Modulation of Orphan Nuclear Receptor Function
|
1R01CA127231-01A2
|
$275,560
|
|
MANI, SRIDHAR
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Immunology and Immunooncology Training Program
|
5T32CA009173-35
|
$656,006
|
|
NATHENSON, Stanley
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Proteomic analysis of head & neck squamous cell cancer
|
5R33CA103547-05
|
$695,192
|
|
PRYSTOWSKY, MICHAEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
The Library-Based Health Partnership Project
|
7R01CA119991-04
|
$522,226
|
|
Rapkin, Bruce
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Transition State Analogues as Modulators of DNA Methylation
|
5R01CA135405-02
|
$270,000
|
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Hematopoietic Stem Cell Differentiation to Macrophages
|
2R01CA032551-26A2
|
$479,119
|
|
STANLEY, E
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Lectin Resistant Tumor Cells and Functional Glycomics
|
5R01CA036434-26
|
$442,918
|
|
STANLEY, PAMELA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Transcriptional regulation of leukemic stem cells in acute myeloid leukemia
|
4R00CA131503-02
|
$249,000
|
|
Steidl, Ulrich
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-06
|
$660,173
|
$660,173
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of macroH2A variants in cancer and senescence
|
5R01CA155232-08
|
$382,013
|
$382,013
|
GAMBLE, MATTHEW
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
$364,614
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Identification and targeting of pathways separating healthy stem cell aging from malignant transformation
|
1R01CA230756-01
|
$382,013
|
$382,013
|
WILL, BRITTA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Innovative Tools for the Molecular Diagnosis of Cancer
|
5R44CA105622-03
|
$260,859
|
|
HENKENS, ROBERT
|
ALDERON BIOSCIENCES, INC.
|
|
Field of Injury Based Biomarkers for Lung Cancer
|
1R44CA139803-01A1
|
$277,875
|
|
Brody, Jerome
|
ALLEGRO DIAGNOSTICS, INC.
|
|
A chemoenzymatic technology for the efficient synthesis of novel cryptophycins
|
1R41CA135869-01A1
|
$322,693
|
|
SHERMAN, DAVID
|
ALLUVIUM BIOSCIENCES, INC.
|
|
A Pb-212 Generator Using Resistant Substrate and Rn Cold Trapping
|
1R41CA135857-01A1
|
$111,339
|
|
Ehrhardt, Gary
|
ALPHAMED, INC
|
|
Soluble TCR-IL15 Fusions as Targeted Therapeutics for Cancer
|
1R43CA139810-01
|
$202,736
|
|
Rhode, Peter
|
ALTOR BIOSCIENCE CORPORATION
|
|
Bifunctional T cell receptor based immunotherapeutics
|
2R44CA097550-05A1
|
$1,000,000
|
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
Optimize RNA-aptamer for Biomarker Molecule CD30
|
1R43CA141842-01
|
$123,605
|
|
Yang, Xianbin
|
AM BIOTECHNOLOGIES, LLC
|
|
Novel Methods for Molecular Analysis of Colorectal Cancer Tissue
|
2R44CA121473-02A2
|
$524,547
|
|
Han, James
|
AMBERGEN, INC
|
|
A Novel Non-Invasive CRC Test Based on Mass Spec Of In Vitro Expressed Proteins
|
5R44CA119565-04
|
$469,320
|
|
Han, James
|
AMBERGEN, INC
|
|
A New Approach for the Non-Invasive Detection of Bladder Cancer
|
1R43CA137986-01A1
|
$187,175
|
|
Sears, Christopher
|
AMBERGEN, INC
|
|
MicroRNA Markers of Melanoma Metastasis in Lymph Nodes
|
1R43CA139700-01
|
$256,920
|
|
Beaudenon, Sylvie
|
AMBION DIAGNOSTICS, INC.
|
|
Identification of microRNA Biomarkers for Lung Cancer
|
1R43CA141786-01
|
$273,456
|
|
Mambo, Elizabeth
|
AMBION DIAGNOSTICS, INC.
|
|
Multiplex Detection of Mutations in Leukemia Patients
|
2R44CA130501-02
|
$609,861
|
|
YE, FEI
|
AMBION DIAGNOSTICS, INC.
|
|
Fifth International Conference on Tumor Microenvironment: Progression, Therapy a
|
1R13CA144431-01
|
$17,000
|
|
DeClerck, Yves
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Pathobiology of Cancer Workshop
|
3R25CA058981-16S1
|
$199,999
|
|
LEHMAN, JOHN
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
Total relevant funding to Aging for this search: $99,440,084
|